These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

45 related articles for article (PubMed ID: 1925979)

  • 21. Localization of silencer and enhancer elements in the human type X collagen gene.
    Beier F; Vornehm S; Pöschl E; von der Mark K; Lammi MJ
    J Cell Biochem; 1997 Aug; 66(2):210-8. PubMed ID: 9213222
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regulation of the collagen II gene in vitro and in transgenic mice.
    Yamada Y; Miyashita T; Savagner P; Horton W; Brown KS; Abramczuk J; Xie HX; Kohno K; Bolander M; Bruggeman L
    Ann N Y Acad Sci; 1990; 580():81-7. PubMed ID: 2337307
    [No Abstract]   [Full Text] [Related]  

  • 23. Cell lineage ablation in transgenic mice by cell-specific expression of a toxin gene.
    Palmiter RD; Behringer RR; Quaife CJ; Maxwell F; Maxwell IH; Brinster RL
    Cell; 1987 Jul; 50(3):435-43. PubMed ID: 3649277
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Morphological abnormalities, neonatal mortality, and reproductive abnormalities in mice transgenic for diphtheria toxin genes that are driven by the promoter for adipocyte lipid binding protein.
    Homanics GE
    Dev Genet; 1991; 12(5):371-9. PubMed ID: 1806333
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tissue-specific expression of the human type II collagen gene in mice.
    Lovell-Badge RH; Bygrave A; Bradley A; Robertson E; Tilly R; Cheah KS
    Proc Natl Acad Sci U S A; 1987 May; 84(9):2803-7. PubMed ID: 3033664
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genetic ablation: targeted expression of a toxin gene causes microphthalmia in transgenic mice.
    Breitman ML; Clapoff S; Rossant J; Tsui LC; Glode LM; Maxwell IH; Bernstein A
    Science; 1987 Dec; 238(4833):1563-5. PubMed ID: 3685993
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transcriptional regulation of the human type X collagen gene expression.
    Beier F; Lammi MJ; Bertling W; von der Mark K
    Ann N Y Acad Sci; 1996 Jun; 785():209-11. PubMed ID: 8702131
    [No Abstract]   [Full Text] [Related]  

  • 28. In vivo footprinting implicates negative regulators in the expression of the type X collagen gene in chickens.
    Long F; Linsenmayer TF
    Ann N Y Acad Sci; 1996 Jun; 785():292-4. PubMed ID: 8702158
    [No Abstract]   [Full Text] [Related]  

  • 29. Complex and diversified regulatory programs control the expression of vertebrate collagen genes.
    Ramirez F; Di Liberto M
    FASEB J; 1990 Apr; 4(6):1616-23. PubMed ID: 2180769
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Subpopulation of Synovial Fibroblasts Leads to Osteochondrogenesis in a Mouse Model of Chronic Inflammatory Rheumatoid Arthritis.
    Miura Y; Ota S; Peterlin M; McDevitt G; Kanazawa S
    JBMR Plus; 2019 Jun; 3(6):e10132. PubMed ID: 31346564
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Induction of an osteoarthritis-like phenotype and degradation of phosphorylated Smad3 by Smurf2 in transgenic mice.
    Wu Q; Kim KO; Sampson ER; Chen D; Awad H; O'Brien T; Puzas JE; Drissi H; Schwarz EM; O'Keefe RJ; Zuscik MJ; Rosier RN
    Arthritis Rheum; 2008 Oct; 58(10):3132-44. PubMed ID: 18821706
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The clinical features of spondyloepiphyseal dysplasia congenita resulting from the substitution of glycine 997 by serine in the alpha 1(II) chain of type II collagen.
    Cole WG; Hall RK; Rogers JG
    J Med Genet; 1993 Jan; 30(1):27-35. PubMed ID: 8423604
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Positive-negative selection gene targeting with the diphtheria toxin A-chain gene in mouse embryonic stem cells.
    McCarrick JW; Parnes JR; Seong RH; Solter D; Knowles BB
    Transgenic Res; 1993 Jul; 2(4):183-90. PubMed ID: 8364601
    [TBL] [Abstract][Full Text] [Related]  

  • 34. SV40 large T antigen expression driven by col2a1 regulatory sequences immortalizes articular chondrocytes but does not allow stabilization of type II collagen expression.
    Steimberg N; Viengchareun S; Biehlmann F; Guénal I; Mignotte B; Adolphe M; Thenet S
    Exp Cell Res; 1999 Jun; 249(2):248-59. PubMed ID: 10366424
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A collagen enhancer-promoter construct in transgenic mice is markedly stimulated by ethanol administration.
    Walton CM; Wu GY; Petruff CA; Clark SH; Lichtler AC; Wu CH
    Hepatology; 1996 Feb; 23(2):310-5. PubMed ID: 8591857
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New genetic approaches to craniofacial growth and malformation in the mouse.
    Brown KS; Yamada Y; Abramczuk J; Kimata K
    J Craniofac Genet Dev Biol; 1991; 11(4):357-65. PubMed ID: 1812135
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Developmental regulation for collagen II gene expression in transgenic mice.
    Bruggeman LA; Xie HX; Brown KS; Yamada Y
    Teratology; 1991 Aug; 44(2):203-8. PubMed ID: 1925979
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Developmental expression of a type II collagen/beta-galactosidase fusion gene in transgenic mice.
    Metsäranta M; Garofalo S; Smith C; Niederreither K; de Crombrugghe B; Vuorio E
    Dev Dyn; 1995 Oct; 204(2):202-10. PubMed ID: 8589444
    [TBL] [Abstract][Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.